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Systematic Review of Randomized Controlled Trials of
Patch Angioplasty Versus Primary Closure and Different
Types of Patch Materials During Carotid Endarterectomy
Kittipan Rerkasem1, Peter M. Rothwell2. 1Department of
Surgery, Chiang Mai University, Chiang Mai, Thailand;
2University of Oxford, Oxford, United Kingdom
Objectives: Patch angioplasty during carotid endarterec-
tomy (CEA)may reduce the risk for perioperative or late carotid
artery recurrent stenosis and subsequent ischemic stroke. We
performed a systematic review of randomized controlled trials to
assess the effect of routine or selective carotid patch angioplasty
compared with CEA with primary closure, and the effect of
different materials used for carotid patch angioplasty.
Methods: Randomized trials during 1966-2009 were
included if they compared carotid patch angioplasty with
primary closure in any patients undergoing CEA or use of
one type of carotid patch with another.
Results: Twenty-three eligible randomized trials were
identified. Ten trials involving 2157 operations compared
primary closure with routine patch closure, and thirteen
trials with 2083 operations compared different patch ma-
terials. Patch angioplasty was associated with a reduction in
risk for ipsilateral stroke during the perioperative period
(p 0.001), and long-term follow-up (p 0.001). Patch-
ing was also associated with reduced risk for perioperative
arterial occlusion (P .0001) and decreased recurrent ste-
nosis during long-term follow-up (p 0.001). Seven trials
that compared between vein and synthetic patches showed
that apart from psudoanaeurysmal formation, there were
no significant different in the outcome between vein patch
and synthetic materials in either the short- or long-term.
There were significantly fewer pseudoaneurysms associated
with synthetic patches than vein patches (p  0.005).
Conclusions: Carotid patch angioplasty decreases the
risk for both ipsilateral stroke in both perioperative and
long-term risk. More data are required to establish differ-
ences between various patch materials.
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With Open Carotid or Subclavian Artery Revascular-
ization
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Objectives: To evaluate the outcomes of retrograde
supra-aortic stent placement (RSAS) combined with open
carotid or subclavian artery revascularization.Methods: We retrospectively reviewed all patients who
had open carotid or subclavian artery revascularization
combined with RSAS of the common carotid (CCA) or
innominate arteries (IA) between 1995 and 2008. Isolated
percutaneous or retrograde stent placements via carotid
artery cutdown were excluded.
Results: 11 patients (2 male and 9 female, mean age 66
years) underwent RSAS of 10 CCA and 1 IA lesions combined
withopen revascularization.Fivepatientshad symptomatic and3
had asymptomatic high-grade carotid stenoses or upper extrem-
ity claudication equivalent. Open revascularization included ca-
rotid endarterectomy in 6 patients, carotid-subclavian bypass in
3, and carotid-carotid bypass in 2. There were no early compli-
cations and the average hospital stay was 3 1 days. All symp-
tomatic patients improved and therewere no recurrent ipsilateral
neurological or upper extremity symptoms. Over a mean fol-
low-up of 19 months, one patient developed CCA in-stent
restenosis which was treated with subclavian-carotid bypass and
later had a contralateral stroke. There were no restenoses or
reinterventions related to open revascularization.
Conclusions: Retrograde common carotid or innominate
artery stentplacement is a safe andeffective treatment for selected
patients with severe supra-aortic inflow disease who require con-
comitant open carotid or subclavian artery reconstructions.
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Aspirin vs Aspirin/Plavix in the Prevention of Stroke:
A Meta-analysis
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Objectives: Antiplatelet therapy reduces the rate of
cardiovascular events in patients with atherosclerotic vascu-
